| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |